Steven D. Kehoe

FDA investigator

Appears on 4 documents from 2015 to 2016, mostly at sites in India. Most often cites production record review (21 CFR 211.192).

4
Documents on file
3.0
Observations per 483
2015
First seen
2016
Most recent

What they cite most

From 12 observations

Activity by year

2015: 1, 2016: 3

Where

India 2 · China 1 · Spain 1

Often inspects with

Daniel J. Roberts· Felix Maldonado

Is Steven D. Kehoe coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Sun Pharmaceuticals Industries, IncNov 16, 2016 · S.A.S. Nagar, Mohali, India
483 Urquima, S.A.Sep 29, 2016 · Sant Fost de Campsentelles, Spain
483 Sun Pharmaceuticals Industries, Inc. SEZ Unit-l, Plot A-41, Industrial Area, Phase VIII-AJul 16, 2016 · S.A.S, India
483 Guilin Pharmaceutical Co., LtdMar 13, 2015 · Guilin, China

About this profile

What does Steven D. Kehoe inspect?

Steven D. Kehoe appears on 4 documents on file covering 3 sites, mostly in India.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.100 and 21 CFR 211.110.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Steven D. Kehoe is dated Nov 16, 2016.